Flagship Pioneering Fund VII General Partner LLC

Insider Reports History

Location
Cambridge, MA
Signature
Flagship Pioneering Fund VII General Partner LLC, By: Flagship Pioneering, Inc., its manager, By: /s/ Noubar B. Afeyan, PhD., Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Flagship Pioneering Fund VII General Partner LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. 10%+ Owner Common Stock 1,329,324 $10,634,592 $8.00 27 Feb 2023 By Flagship Pioneering Fund VII, L.P.
Seres Therapeutics, Inc. 10%+ Owner Common Stock 5,825,495 $7,864,418 $1.35 05 Jul 2022 By Flagship Pioneering Fund VII, L.P.
Evelo Biosciences, Inc. 10%+ Owner Common Stock 13,698,630 $4,520,548 $0.3300 27 May 2022 By Flagship Pioneering Fund VII, L.P.

Insider Reports Filed by Flagship Pioneering Fund VII General Partner LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FHTX Foghorn Therapeutics Inc. 22 May 2024 0 $0 3 10%+ Owner 24 May 2024, 17:00
SANA Sana Biotechnology, Inc. 12 Feb 2024 0 $0 3 10%+ Owner 14 Feb 2024, 16:00
OMGAQ Omega Therapeutics, Inc. 27 Feb 2023 0 $0 3 10%+ Owner 27 Feb 2023, 16:20
MCRB Seres Therapeutics, Inc. 05 Jul 2022 0 $0 3 10%+ Owner 07 Jul 2022, 17:00
/report/000089924322020532-flagship-pioneering-fund-vii-general-partner-llc-2022-05-27 Evelo Biosciences, Inc. 27 May 2022 0 $0 3 10%+ Owner 01 Jun 2022, 19:00